The Many Treatment Options for Non-Melanoma Skin Cancer
What Are the Types of Non-Melanoma Skin Cancer? First, for some clarification, because before we talk in depth about non-melanoma skin cancer, from its causes to its cure options to symptoms, skin cancer prognoses, and everything in between, it’s important to clearly distinguish melanoma from non-melanoma skin cancer. Melanoma skin cancer is a very serious […]
Non-Melanoma Skin Cancer & What You Probably Did Not Know
Non-melanoma skin cancer has reportedly increased “33% since 2012” (Practical Dermatology, September 2019). For these skin cancer-related cases, there was reportedly “3.5 million total procedures in 2018… 3.35 million being for non-melanoma skin cancer” (Practical Dermatology, September 2019). With these increasing numbers, persons are turning to their local physicians for skin cancer checks. What physicians […]
What is Superficial Radio Therapy? (SRT)
What is Superficial Radio Therapy? Superficial Radio Therapy is the latest non-invasive, non-melanoma skin cancer treatment option. Superficial Radio Therapy is administered with the use of the SRT-100™, our state-of-the-art system inspired by the tried-and-true Superficial Radio Therapy systems that were once the proven gold standard among dermatologists and radiation oncologists. The difference? Our machine […]
SRT-100™: A Non-Melanoma Skin Cancer Treatment Your Body Can Handle, but Cancer Cannot
Skin cancer is the fastest growing cancer in the world. Experts predict the number of people diagnosed with non-melanoma skin cancer will grow to nearly six million by the year 2020. With the epidemic of basal and squamous cell skin cancer diagnosis follows the common and less than ideal solution of surgical non-melanoma skin cancer […]
Palliative Radiotherapy For Non-Melanoma Skin Cancer
Barnes EA, Breen D, Culleton S, Zhang L, Kamra J, Tsao M, Balogh J. Palliative radiotherapy for non-melanoma skin cancer. ClinOncol (R CollRadiol). 2010 Dec;22(10):844-9. Epub 2010 Aug 15. Department of Radiation Oncology, Odette Cancer Centre, Toronto, Ontario, Canada. [email protected] AIMS: The primary objective of this study was to assess the rate of tumor response to the […]
